Actuate Therapeutics, Inc. · NASDAQ:ACTU
Actuate Therapeutics, Inc. shareholders
As of Sep 30, 2026, 38 institutions reported holding Actuate Therapeutics, Inc., 22.0% of its shares. Largest: BIOS Capital Management, LP, Voss Capital, LP and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Actuate Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BIOS Capital Management, LP | 10M | 16.6% | no change | Nov 13, 2026 |
| Voss Capital, LP | 1.9M | 3.1% | +174K | Nov 16, 2026 |
| Vanguard | 453K | 0.75% | no change | Nov 13, 2026 |
| Geode Capital | 104K | 0.17% | −8,239 | Nov 6, 2026 |
| Texas Capital Bank Wealth Management Services Inc | 103K | 0.17% | no change | Nov 9, 2026 |
| Palogic Value Management, L.P. | 100K | 0.17% | no change | Nov 16, 2026 |
| Millennium | 90,195 | 0.15% | −6,489 | Nov 16, 2026 |
| ABS Investment Management LLC | 73,186 | 0.12% | no change | Nov 16, 2026 |
| BlackRock | 66,944 | 0.11% | −23,091 | Nov 13, 2026 |
| Rock Creek Group LLC | 50,000 | 0.08% | +10,737 | Nov 9, 2026 |